XML 80 R68.htm IDEA: XBRL DOCUMENT v3.22.1
Subsequent Events (Details) - Subsequent event
$ / shares in Units, $ in Millions
May 09, 2022
USD ($)
$ / shares
Apr. 04, 2022
USD ($)
shares
Channel    
Subsequent Events    
Upfront cash payment   $ 35.0
Stock issued in acquisition, number of shares | shares   493,254
Stock issued in acquisition   $ 65.0
Potential developmental and regulatory milestones on BHV-7000   325.0
Potential developmental and regulatory milestones on Kv7 pipeline development   250.0
Potential commercial sales based milestones of BHV-7000   $ 562.5
Pfizer | Biohaven    
Subsequent Events    
Transaction cash consideration $ 11,600.0  
Price per share to be acquired (in dollars per share) | $ / shares $ 148.50  
Share ratio of new publicly traded company per two shares to existing shareholders 1  
New Biohaven    
Subsequent Events    
Post merger capitalization $ 275.0  
Net sales threshold for tiered royalty rights $ 5,250.0